Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Use of metronomic chemotherapy in oncology: results from a national Italian survey.

Collovà E, Sebastiani F, De Matteis E, Generali D, Aurilio G, Boccardo F, Crispino S, Cruciani G.

Tumori. 2011 Jul-Aug;97(4):454-8. doi: 10.1700/950.10397.

2.

Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).

Gori S, Di Maio M, Pinto C, Alabiso O, Baldini E, Barbato E, Beretta GD, Bravi S, Caffo O, Canobbio L, Carrozza F, Cinieri S, Cruciani G, Dinota A, Gebbia V, Giustini L, Graiff C, Molino A, Muggiano A, Pandoli G, Puglisi F, Tagliaferri P, Tomao S, Lunardi G, Venturini M; AIOM Working Group “Interaction with Regional Sections” (2009-2011).

Tumori. 2013 Jan-Feb;99(1):35-8. doi: 10.1700/1248.13785.

PMID:
23548997
3.

Metronomic chemotherapy in metastatic breast cancer: impact on VEGF.

El-Arab LR, Swellam M, El Mahdy MM.

J Egypt Natl Canc Inst. 2012 Mar;24(1):15-22. doi: 10.1016/j.jnci.2011.12.002. Epub 2012 Jan 17.

4.

A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer.

Saridaki Z, Malamos N, Kourakos P, Polyzos A, Ardavanis A, Androulakis N, Kalbakis K, Vamvakas L, Georgoulias V, Mavroudis D.

Cancer Chemother Pharmacol. 2012 Jan;69(1):35-42. doi: 10.1007/s00280-011-1663-3. Epub 2011 May 18.

PMID:
21590447
5.

Patterns of practice in the radiation therapy management of rectal cancer: survey of the Interregional Group Piedmont, Valle d'Aosta and Liguria of the "Associazione Italiana di Radioterapia Oncologica (AIRO)".

Di Genesio Pagliuca M, Turri L, Munoz F, Melano A, Bacigalupo A, Franzone P, Sciacero P, Tseroni V, Vitali ML, Delmastro E, Scolaro T, Marziano C, Orsatti M, Tessa M, Rossi A, Ballare A, Moro G, Grasso R, Krengli M.

Tumori. 2013 Jan-Feb;99(1):61-7. doi: 10.1700/1248.13790.

PMID:
23549002
6.

Metronomic chemotherapy against cancer: from paradigm to clinical practice?

Calvani N, Orlando L, Nacci A, Sponziello F, Cinefra M, Cinieri S.

Tumori. 2009 Nov-Dec;95(6):843-5.

7.

Chemotherapy-induced anemia and oncologist perception on treatment: results of a web-based survey.

Cortinovis D, Beretta G, Piazza E, Luchena G, Aglione S, Bertolini A, Buzzoni R, Cabiddu M, Carnaghi C, Danova M, Farina G, Ferrari V, Frascaroli M, Reni M, Tansini G; AIOM Lombardia.

Tumori. 2013 Jan-Feb;99(1):45-50. doi: 10.1700/1248.13787.

PMID:
23548999
9.

Radiotherapy in Italy for non-small cell lung cancer: patterns of care survey.

Ramella S, Maranzano E, Frata P, Mantovani C, Lazzari G, Menichelli C, Navarria P, Pergolizzi S, Salvi F.

Tumori. 2012 Jan-Feb;98(1):66-78. doi: 10.1700/1053.11502.

PMID:
22495704
10.
11.

Metronomics chemotherapy: time for computational decision support.

Barbolosi D, Ciccolini J, Meille C, Elharrar X, Faivre C, Lacarelle B, André N, Barlesi F.

Cancer Chemother Pharmacol. 2014 Sep;74(3):647-52. doi: 10.1007/s00280-014-2546-1. Epub 2014 Aug 1. Review.

PMID:
25082520
12.

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.

Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, Klement G, Laforme A, Gordon A, Thomas A, Neuberg D, Browder T, Folkman J.

J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81.

PMID:
16282886
13.

Metronomic chemotherapy for cancer treatment: a decade of clinical studies.

Romiti A, Cox MC, Sarcina I, Di Rocco R, D'Antonio C, Barucca V, Marchetti P.

Cancer Chemother Pharmacol. 2013 Jul;72(1):13-33. doi: 10.1007/s00280-013-2125-x. Epub 2013 Mar 9. Review.

PMID:
23475105
14.

Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany.

Sinn M, Bischoff S, Nehls O, Pelzer U, von Weizsäcker F, Kubicka S, Stieler JM, Caca K, Riess H.

Onkologie. 2012;35(12):755-60. doi: 10.1159/000345115. Epub 2012 Nov 20.

PMID:
23207621
15.

Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer.

Fedele P, Marino A, Orlando L, Schiavone P, Nacci A, Sponziello F, Rizzo P, Calvani N, Mazzoni E, Cinefra M, Cinieri S.

Eur J Cancer. 2012 Jan;48(1):24-9. doi: 10.1016/j.ejca.2011.06.040. Epub 2011 Jul 19.

PMID:
21775129
16.

Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.

Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.

Neuro Oncol. 2007 Jul;9(3):354-63. Epub 2007 Apr 23.

17.

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.

Wong NS, Buckman RA, Clemons M, Verma S, Dent S, Trudeau ME, Roche K, Ebos J, Kerbel R, Deboer GE, Sutherland DJ, Emmenegger U, Slingerland J, Gardner S, Pritchard KI.

J Clin Oncol. 2010 Feb 10;28(5):723-30. doi: 10.1200/JCO.2009.24.0143. Epub 2009 Dec 21.

PMID:
20026801
18.

The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.

Ekinci D, Kargi A, Yalcin AD, Savas B.

J BUON. 2013 Jan-Mar;18(1):245-52. Erratum in: J BUON. 2013 Jul-Sep;18(3):807. Ekici, D [corrected to Ekinci, D]; Didem Yalcin, A [corrected to Yalcin, A D].

PMID:
23613412
19.

Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.

Cocconi G, Bisagni G, Bella M, Acito L, Anastasi P, Carpi A, Di Costanzo F, Frassoldati A, Mosconi A, Borrini A, Buzzi P.

Am J Clin Oncol. 1999 Dec;22(6):593-600.

PMID:
10597744
20.

Importance of adherence to guidelines in breast cancer clinical practice. The Italian experience (AIOM).

Barni S, Venturini M, Molino A, Donadio M, Rizzoli S, Maiello E, Gori S.

Tumori. 2011 Sep-Oct;97(5):559-63. doi: 10.1700/989.10711.

Supplemental Content

Support Center